Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

COMT inhibitors

Identifieur interne : 004551 ( Main/Exploration ); précédent : 004550; suivant : 004552

COMT inhibitors

Auteurs :

Source :

RBID : ISTEX:E35A22755A6CEACFB859E1ECC748766EAF0A43B2

English descriptors


Url:
DOI: 10.1002/mds.5560


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">COMT inhibitors</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E35A22755A6CEACFB859E1ECC748766EAF0A43B2</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.5560</idno>
<idno type="url">https://api.istex.fr/document/E35A22755A6CEACFB859E1ECC748766EAF0A43B2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001D33</idno>
<idno type="wicri:Area/Istex/Curation">001D33</idno>
<idno type="wicri:Area/Istex/Checkpoint">002E43</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12211139</idno>
<idno type="wicri:Area/PubMed/Corpus">003985</idno>
<idno type="wicri:Area/PubMed/Curation">003985</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003B74</idno>
<idno type="wicri:Area/Ncbi/Merge">000866</idno>
<idno type="wicri:Area/Ncbi/Curation">000866</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000866</idno>
<idno type="wicri:Area/Main/Merge">006557</idno>
<idno type="wicri:Area/Main/Curation">004551</idno>
<idno type="wicri:Area/Main/Exploration">004551</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">COMT inhibitors</title>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-07">2002-07</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">S4</biblScope>
<biblScope unit="supplement">4</biblScope>
<biblScope unit="page" from="S45">S45</biblScope>
<biblScope unit="page" to="S51">S51</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">E35A22755A6CEACFB859E1ECC748766EAF0A43B2</idno>
<idno type="DOI">10.1002/mds.5560</idno>
<idno type="ArticleID">MDS5560</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiparkinson Agents (pharmacokinetics)</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Benzophenones (pharmacokinetics)</term>
<term>Benzophenones (pharmacology)</term>
<term>Benzophenones (therapeutic use)</term>
<term>Brain (metabolism)</term>
<term>Catechol O-Methyltransferase Inhibitors</term>
<term>Catechols (pharmacokinetics)</term>
<term>Catechols (pharmacology)</term>
<term>Catechols (therapeutic use)</term>
<term>Humans</term>
<term>Nitriles</term>
<term>Nitrophenols</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Psychomotor Disorders (prevention & control)</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Benzophenones</term>
<term>Catechols</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Benzophenones</term>
<term>Catechols</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Benzophenones</term>
<term>Catechols</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Psychomotor Disorders</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Catechol O-Methyltransferase Inhibitors</term>
<term>Humans</term>
<term>Nitriles</term>
<term>Nitrophenols</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004551 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004551 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:E35A22755A6CEACFB859E1ECC748766EAF0A43B2
   |texte=   COMT inhibitors
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024